BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31732464)

  • 1. Impact of surgical wait times on oncologic outcomes in resectable pancreas adenocarcinoma.
    Vasilyeva E; Li J; Desai S; Chung SW; Scudamore CH; Segedi M; Kim PT
    HPB (Oxford); 2020 Jun; 22(6):892-899. PubMed ID: 31732464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resectable pancreas adenocarcinoma: the longer the wait time, the longer the oncologic survival?
    Chen ZL; Yang T; Liang YJ
    HPB (Oxford); 2020 May; 22(5):789. PubMed ID: 32051091
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to letter "resectable pancreas adenocarcinoma: the longer the wait time, the longer the oncologic survival?".
    Vasilyeva E; Li J; Desai S; Scudamore C; Segedi M; Chung S; Kim P
    HPB (Oxford); 2020 Jun; 22(6):934. PubMed ID: 32291176
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of wait times on oncological outcomes from periampullary adenocarcinomas.
    McLean SR; Karsanji D; Wilson J; Dixon E; Sutherland FR; Pasieka J; Ball C; Bathe OF
    J Surg Oncol; 2013 Jun; 107(8):853-8. PubMed ID: 23625192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of wait times on survival for women with uterine cancer.
    Elit LM; O'Leary EM; Pond GR; Seow HY
    J Clin Oncol; 2014 Jan; 32(1):27-33. PubMed ID: 24276779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck.
    Zheng Z; Tan C; Chen Y; Ping J; Wang M
    PLoS One; 2019; 14(5):e0217427. PubMed ID: 31125386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?
    Healy GM; Redmond CE; Murphy S; Fleming H; Haughey A; Kavanagh R; Swan N; Conlon KC; Malone DE; Ryan ER
    Abdom Radiol (NY); 2018 Mar; 43(3):620-628. PubMed ID: 28695235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.
    Matsubayashi H; Infante JR; Winter J; Klein AP; Schulick R; Hruban R; Visvanathan K; Goggins M
    Cancer Biol Ther; 2007 Oct; 6(10):1569-75. PubMed ID: 18000398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
    Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
    Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
    Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
    J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group.
    Elberm H; Ravikumar R; Sabin C; Abu Hilal M; Al-Hilli A; Aroori S; Bond-Smith G; Bramhall S; Coldham C; Hammond J; Hutchins R; Imber C; Preziosi G; Saleh A; Silva M; Simpson J; Spoletini G; Stell D; Terrace J; White S; Wigmore S; Fusai G
    Eur J Surg Oncol; 2015 Nov; 41(11):1500-7. PubMed ID: 26346183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma.
    Brahmania M; Ahmed O; Kelley M; Wong D; Kowgier M; Khalili K; Beecroft R; Renner EL; Shah H; Feld J; Janssen HLA; Sherman M
    Ann Hepatol; 2017; 16(5):765-771. PubMed ID: 28809734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival.
    Helewa RM; Turner D; Park J; Wirtzfeld D; Czaykowski P; Hochman D; Singh H; Shu E; McKay A
    J Surg Oncol; 2013 Nov; 108(6):378-84. PubMed ID: 24037666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of the exocrine pancreas. A plea for resection.
    Huguier M; Baumel H; Manderscheid JC
    Hepatogastroenterology; 1996; 43(9):721-9. PubMed ID: 8799420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.